Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 257 citing Montori: Posttransplantation diabetes. (0.07 sec) 

Diabetes mellitus after kidney transplantation in the United States


BL Kasiske, JJ Snyder, D Gilbertson, AJ … - American Journal of …, 2003 - interscience.wiley.com
New onset diabetes is a major complication after kidney transplantation. However, the
incidence, risk factors and clinical relevance of post-transplant diabetes mellitus (PTDM) vary
among reports from single-center observational studies and clinical trials. Using data from ...
Cited by 466 - Related articles - BL Direct - All 6 versions

New-onset diabetes after transplantation 2003 International Consensus Guidelines


JA Davidson, A Wilkinson - Diabetes Care, 2004 - Am Diabetes Assoc
New-onset diabetes and impaired glucose tolerance (IGT) are among the most serious metabolic
complications of solid organ transplantation. Despite the importance of these conditions to the
outcome of transplant recipients, their precise incidence is difficult to determine. This is ...
Cited by 265 - Related articles - BL Direct - All 12 versions

Wound-Healing Complications After Kidney Transplantation: A Prospective, …


PG Dean, WJ Lund, TS Larson, M Prieto, SL Nyberg, … - Transplantation, 2004 - journals.lww.com
Background. Viaspan (University of Wisconsin [UW]) solution is the gold standard for abdominal
or- gan preservation. Celsior (CEL) is an extracellular- type, low-potassium, low-viscosity
solution, initially used for heart and lung preservation. We have per- formed a prospective ...
Cited by 119 - Related articles - BL Direct - All 4 versions

Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus

- nih.gov
KI Rother, DM Harlan - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig
Worldwide, more than 750 individuals with type 1 diabetes mellitus (T1DM) have received allogeneic
islet transplants since 1974, in an effort to cure their chronic condition. Though this is still a small
number (especially when compared with the estimated 1 million afflicted with T1DM and ...
Cited by 103 - Related articles - BL Direct - All 11 versions

Elevated serum concentration of adipose-derived factor, adiponectin, in patients …

- diabetesjournals.org [PDF] 
A Imagawa, T Funahashi, T Nakamura, M Moriwaki, … - Diabetes Care, 2002 - Am Diabetes Assoc
In type 2 diabetes, coronary artery dis- ease (CAD), the major cause of mortal- ity, is often diagnosed
late because of silent myocardial ischemia (MI) (1). Asymptomatic type 2 diabetic patients, particularly
those with additional athero- genic factors predisposing to a more se- vere coronary risk ...
Cited by 92 - Related articles - BL Direct - All 5 versions

New onset hyperglycemia and diabetes are associated with increased …


YK FC… - Kidney international, 2005 - nature.com
Kidney International aims to inform the renal researcher and practicing nephrologists on all
aspects of renal research. Clinical and basic renal research, commentaries, The Renal Consult,
Nephrology sans Frontieres, minireviews, reviews, Nephrology Images, Journal Club. Published ...
Cited by 76 - Related articles - All 4 versions

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor …

- asnjournals.org
A Teutonico, PF Schena, S Di Paolo - Journal of the American Society of …, 2005 - Am Soc Nephrol
Cyclosporine A (CsA) and tacrolimus have been associated with an increased risk for diabetes
after transplantation, whereas sirolimus is deemed to be devoid of any effect on glucose
metabolism. This study was performed to investigate the effect of the withdrawal of ...
Cited by 75 - Related articles - BL Direct - All 5 versions

[PDF] Guidelines for the treatment and management of new-onset diabetes after …


A Wilkinson, J Davidson, F Dotta, PD Home, … - Clin …, 2005 - universityhealthsystem.com
Abstract: Although graft and patient survival after solid organ transplan- tation have improved
markedly in recent years, transplant recipients con- tinue to experience an increased prevalence
of cardiovascular disease (CVD) compared with the general population. A number of ...
Cited by 72 - Related articles - View as HTML - All 6 versions

Drug therapy in the heart transplant recipient: part I: cardiac rejection and …

- ahajournals.org
JA Lindenfeld, GG Miller, SF Shakar, R Zolty, BD … - Circulation, 2004 - Am Heart Assoc
Survival after heart transplantation has improved considerably over the past 20 years. Half of
all patients now live >9 years, and 25% live 17 years. 1 Currently, 20 000 heart transplant recipients
live in the United States. 2 Improved longevity means prolonged immunosuppression and ...
Cited by 65 - Related articles - All 10 versions

Evaluation of the quality of prognosis studies in systematic reviews

- annals.org [PDF] 
JA Hayden, P Cote, C Bombardier - Annals of internal medicine, 2006 - Am Coll Physicians
Background: To provide valid assessments of answers to prognostic questions, systematic reviews
must appraise the quality of the avail- able evidence. However, no standard quality assessment
method is currently available. ... Purpose: To appraise how authors assess the quality of ...
Cited by 69 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google